Regarding anti-hormonal therapy for breast cancer, one study found that aromatase inhibitors resulted in less risk of dementia than tamoxifen treatment [96] while another study found no difference between both treatments in the risk for dementia [97]. The gene discussed is CYP19A1; the disease is breast carcinoma.